2016
DOI: 10.1377/hlthaff.2015.1088
|View full text |Cite
|
Sign up to set email alerts
|

The Social Value Of Vaccination Programs: Beyond Cost-Effectiveness

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
50
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 69 publications
(50 citation statements)
references
References 50 publications
0
50
0
Order By: Relevance
“…In addition to reducing preventable premature mortality, the practice of vaccination is cost‐effective, increasing parent or carer productivity, and lowering health care costs by reducing childhood morbidity (Ozawa 2012; WHO 2018). Childhood vaccination also has a broader social benefit of promoting health equity by ensuring the distribution of health within populations, and contributes to the public good by supporting disease containment (Luyten 2016). …”
Section: Introductionmentioning
confidence: 99%
“…In addition to reducing preventable premature mortality, the practice of vaccination is cost‐effective, increasing parent or carer productivity, and lowering health care costs by reducing childhood morbidity (Ozawa 2012; WHO 2018). Childhood vaccination also has a broader social benefit of promoting health equity by ensuring the distribution of health within populations, and contributes to the public good by supporting disease containment (Luyten 2016). …”
Section: Introductionmentioning
confidence: 99%
“…It is estimated that childhood vaccines currently save 2–3 million lives annually and many more deaths could be averted with an elevated vaccination coverage [ 2 ]. Vaccinations can also minimize inappropriate use of antibiotics by reducing antibiotic use as a result of fewer infections among vaccinated individuals [ 3 , 4 ]. Vaccinations have been shown to have a significant positive effect on child growth by reducing stunting and children being underweight [ 5 ].…”
Section: Introductionmentioning
confidence: 99%
“…Also screening and (non-)pharmaceutical intervention strategies have not been fully explored with IBMs for many diseases. Given the heterogeneous nature of bio-medical and socioeconomic data and the accelerating health care expenditures, IBMs become progressively useful to inform policy makers, particularly in combination with efficiency and equity analyses [ 106 , 107 ]. There are relatively few papers with an IBM for stochastic outbreak analysis under high vaccination coverage, for example for vaccine-preventable childhood diseases.…”
Section: Discussionmentioning
confidence: 99%